Paul John O'Hanlon
Director/Board Member at Avantec Healthcare Ltd.
Paul John O'Hanlon active positions
| Companies | Position | Start | End |
|---|---|---|---|
Avantec Healthcare Ltd.
 Avantec Healthcare Ltd. Medical SpecialtiesHealth Technology Part of Omnicell, Inc., Avantec Healthcare Ltd. provides automated solutions for hospital medication. The company is based in Manchester, UK. The British company was founded in 2004. Avantec Healthcare was acquired by Omnicell, Inc. on April 30, 2015 for $18 million. | Director/Board Member | 29/04/2015 | - |
Career history of Paul John O'Hanlon
Former positions of Paul John O'Hanlon
| Companies | Position | Start | End |
|---|---|---|---|
Omnicell Ltd.
 Omnicell Ltd. Drugstore ChainsRetail Trade Part of Omnicell, Inc., Omnicell Ltd. is a British company that provides medication management solutions and adherence tools for health systems and pharmacies. The company is based in Manchester, UK. The company was founded in 1992 by Randall A. Lipps. Randall A. Lipps has been the CEO since 1992. | Chief Executive Officer | - | 31/03/2020 |
Statistics
International
| United Kingdom | 3 |
Operational
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Retail Trade | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Omnicell Ltd.
Omnicell Ltd. Drugstore ChainsRetail Trade Part of Omnicell, Inc., Omnicell Ltd. is a British company that provides medication management solutions and adherence tools for health systems and pharmacies. The company is based in Manchester, UK. The company was founded in 1992 by Randall A. Lipps. Randall A. Lipps has been the CEO since 1992. | Retail Trade |
Avantec Healthcare Ltd.
Avantec Healthcare Ltd. Medical SpecialtiesHealth Technology Part of Omnicell, Inc., Avantec Healthcare Ltd. provides automated solutions for hospital medication. The company is based in Manchester, UK. The British company was founded in 2004. Avantec Healthcare was acquired by Omnicell, Inc. on April 30, 2015 for $18 million. | Health Technology |
- Stock Market
- Insiders
- Paul John O'Hanlon
- Experience
